Keyphrases
Cognitive Impairment
100%
Pharmacological Model
100%
Scopolamine
100%
Animal Behavioral Studies
100%
High Dose
28%
Cognitive Deficits
28%
Locomotor Activity
28%
Cognitive Function
14%
Healthy Individuals
14%
Sensory Stimuli
14%
Learning Performance
14%
Memory Performance
14%
Mnemonics
14%
Behavioral Processes
14%
Non-cognitive
14%
Animal Behavior
14%
Dose-response Curve
14%
Muscarinic Receptors
14%
Acetylcholine
14%
M1 Antagonist
14%
Memory-guided Attention
14%
Attentional Processes
14%
Healthy Animals
14%
Stimulus Discrimination
14%
Effects on Learning
14%
Intracerebral Injection
14%
Salivation
14%
Pupil Dilation
14%
Non-specific Effects
14%
Taste Aversion
14%
Sensory Attention
14%
Sensory Discrimination
14%
INIS
doses
100%
reviews
100%
animals
100%
psychological behavior
100%
learning
66%
curves
33%
humans
33%
drugs
33%
injection
33%
side effects
33%
stimuli
33%
performance
33%
acetylcholine
33%
Psychology
Cognitive Impairment
100%
Scopolamine
100%
Discrimination
28%
Cognitive Deficit
28%
Learning and Memory
28%
Locomotion
28%
Cognitive Function
14%
Mnemonics
14%
Sensory Stimulus
14%
Taste Aversion
14%
Short-Term Memory
14%
Neuroscience
Cognitive Disorders
100%
Scopolamine
100%
Locomotor Activity
28%
Behavior (Neuroscience)
28%
Cognitive Function
14%
Short-Term Memory
14%
Cholinergic
14%
Acetylcholine
14%
Taste Aversion
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cognitive Defect
100%
Scopolamine
100%
Normal Human
14%
Side Effect
14%
Acetylcholine
14%
Cholinergic Receptor Stimulating Agent
14%
Muscarinic M1 Receptor Antagonist
14%